荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09995 荣昌生物

未开盘 08-13 16:08:14

82.500

+0.200

+0.24%

最高86.100	最低81.400	成交量359.56万
今开82.850	昨收82.300	日振幅5.71%
总市值464.98亿	流通市值172.08亿	总股本5.64亿
成交额3.03亿	换手率1.72%	流通股本2.09亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"荣昌生物","latestPrice":82.5,"timestamp":1786608494009,"preClose":82.3,"halted":0,"volume":3595600,"delay":0,"changeRate":0.002430133657351189,"floatShares":208581239,"shares":563608243,"eps":1.500756856436615,"marketStatus":"未开盘","change":0.2,"latestTime":"08-13 16:08:14","open":82.85,"high":86.1,"low":81.4,"amount":302695145,"amplitude":0.057108,"askPrice":82.55,"askSize":1000,"bidPrice":82.5,"bidSize":12500,"shortable":3,"etf":0,"ttmEps":2.715785894691412,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786671000000},"marketStatusCode":0,"adr":0,"listingDate":1604851200000,"exchange":"SEHK","adjPreClose":82.3,"openAndCloseTimeList":[[1786584600000,1786593600000],[1786597200000,1786608000000]],"volumeRatio":0.686591,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"荣昌生物","latestPrice":131.87,"timestamp":1786604400000,"preClose":129.76,"halted":0,"volume":9997000,"delay":0,"premium":"-46.22"}},"requestUrl":"/m/hq/s/09995/tweets","defaultTab":"tweets","newsList":[{"id":"2659306138","title":"海量财经 | 营收预增433%实现扭亏 荣昌生物披露2026年半年度业绩预告","url":"https://stock-news.laohu8.com/highlight/detail?id=2659306138","media":"海报新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659306138?lang=zh_cn&edition=full","pubTime":"2026-08-13 12:15","pubTimestamp":1786594500,"startTime":"0","endTime":"0","summary":"8月10日—12日，荣昌生物（688331）融资余额从10.76亿增至11.27亿，连续三日净买入超7000万元；而在一周前的8月6日，公司刚披露2026年上半年业绩预告，预计上半年净利约47亿元同比扭亏，融资与业绩利好释放节奏基本同步。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608133840273072.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608133840273072.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09995","688331"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164302324","title":"荣昌生物（09995）定于8月24日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1164302324","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164302324?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:37","pubTimestamp":1786523879,"startTime":"0","endTime":"0","summary":"荣昌生物制药（烟台）股份有限公司（09995）8月12日公告称，公司董事会将于2026年8月24日（星期一）召开会议，审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩及其刊发事宜。\n根据公告，董事会现由9名成员组成，包括执行董事王威东、房健民、温庆凯、房艺及王玉晓；非执行董事王荔强；独立非执行董事宋希亮、黄国滨及陈云金。\n上述会议结果及相关中期业绩报告一经董事会通过，预计将按规定及时对外发布。公司提醒投资者关注后续公告。\n本公告由董事长兼执行董事王威东代表董事会签署，公告日期为2026年8月12日。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111083468","title":"异动解读 | 荣昌生物盘中大涨5.10%，半年度业绩扭亏为盈持续催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1111083468","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111083468?lang=zh_cn&edition=full","pubTime":"2026-08-10 09:48","pubTimestamp":1786326518,"startTime":"0","endTime":"0","summary":"荣昌生物(09995)今日盘中大涨5.10%，引发市场关注。消息面上，公司此前披露的半年度业绩预告显示，预计上半年营收约58.5亿元，同比增长约433%；归母净利润约47亿元，较上年同期净亏损4.5亿元实现扭亏为盈。业绩大幅增长主要受益于核心产品泰它西普、维迪西妥单抗国内销售持续放量，以及与艾伯维就RC148签署独家授权许可协议带来的技术授权收入（首付款6.5亿美元）大幅增加。此外，新版国家基本药物目录近期发布，公司关键品种有望迎来进一步放量机会，生物科技板块整体走强也对股价形成了联动效应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121536900","title":"异动解读｜荣昌生物盘中上涨3.88%，半年度业绩预告扭亏为盈持续催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1121536900","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121536900?lang=zh_cn&edition=full","pubTime":"2026-08-10 09:46","pubTimestamp":1786326367,"startTime":"0","endTime":"0","summary":"8月10日，荣昌生物盘中上涨3.88%，报90.0港元，成交额1.22亿港元。消息面上，公司此前披露半年度业绩预告，预计上半年营收约58.5亿元，同比增长约433%；归母净利润约47亿元，较上年同期净亏损4.5亿元实现扭亏为盈。业绩大幅增长主要受益于核心产品泰它西普、维迪西妥单抗国内销售持续放量，以及与艾伯维就RC148签署独家授权许可协议带来的技术授权收入（首付款6.5亿美元）大幅增加。此外，新版国家基本药物目录近期发布，公司关键品种有望迎来进一步放量机会，生物科技板块整体走强形成联动效应。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658736336","title":"每周股票复盘：荣昌生物（688331）H1净利预盈47亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2658736336","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658736336?lang=zh_cn&edition=full","pubTime":"2026-08-09 01:15","pubTimestamp":1786209313,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，荣昌生物报收于132.99元，较上周的113.05元上涨17.64%。本周，荣昌生物8月7日盘中最高价报134.99元。荣昌生物当前最新总市值750.7亿元，在生物制品板块市值排名1/51，在两市A股市值排名268/5205。本周关注点业绩披露要点：荣昌生物预计2026年1-6月归属净利润盈利约47亿元。公司公告汇总：荣昌生物已实施股份回购，累计回购13,000股，支付资金142.82万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2328871848.SGD","BK0239","LU1064131003.USD","688331","09995","BK1583","BK1161","BK1574","LU2488822045.USD","LU1969619763.USD","LU2148510915.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657616539","title":"8月7日荣昌生物涨11.61%，万家行业优选LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657616539","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657616539?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:41","pubTimestamp":1786092103,"startTime":"0","endTime":"0","summary":"证券之星消息，8月7日荣昌生物涨11.61%，收盘报132.99元，换手率4.16%，成交量14.82万手，成交额18.75亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共121家，其中持有数量最多的公募基金为万家基金的万家行业优选LOF。万家行业优选LOF的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700028026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","LU1969619763.USD","09995","LU2148510915.USD","LU2328871848.SGD","160916","LU1064131003.USD","BK1583","LU2488822045.USD","BK1574","BK1161","688331","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657695557","title":"港股异动 | 荣昌生物(09995)午前涨超5% 中期维度首次实现大规模盈利 海外授权贡献显著","url":"https://stock-news.laohu8.com/highlight/detail?id=2657695557","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657695557?lang=zh_cn&edition=full","pubTime":"2026-08-07 11:54","pubTimestamp":1786074859,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荣昌生物午前涨超5%，截至发稿，涨5.6%，报83.95港元，成交额2.98亿港元。消息面上，荣昌生物发布盈喜，预计上半年营业收入约58.50亿元，同比增长逾4.3倍；预计实现归母净利润47亿元，扣非归母净利润约 43.00 亿元。据悉，今年1月，荣昌生物与艾伯维签署RC148海外权益授权，交易总金额最高可达56亿美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477179.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","LU1064130708.USD","LU1969619763.USD","LU2148510915.USD","BK1574","KCAI","BK1161","BK0239","09995","688331","BK4588","BK1583","BK4585","LU2328871848.SGD","VXUS","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164465310","title":"异动解读｜荣昌生物盘中上涨5.03%，上半年扭亏为盈叠加基药目录政策催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1164465310","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164465310?lang=zh_cn&edition=full","pubTime":"2026-08-07 11:21","pubTimestamp":1786072910,"startTime":"0","endTime":"0","summary":"8月7日，荣昌生物盘中上涨5.03%，报83.5港元，成交额2.68亿港元。消息面上，公司近日披露中期业绩预告，预计上半年营收约58.5亿元，同比增长约433%；归母净利润约47亿元，较上年同期净亏损4.5亿元实现扭亏为盈。业绩大幅增长主要得益于核心产品泰它西普、维迪西妥单抗国内销售收入持续增长，以及与艾伯维就RC148签署独家授权许可协议带来的技术授权收入大幅增加。此外，新版国家基本药物目录近期正式发布，交银国际研报指出荣昌生物关键品种有望迎来放量机会，医药板块今日整体走强形成联动效应。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读｜荣昌生物盘中上涨5.03%，上半年扭亏为盈叠加基药目录政策催化","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657660793","title":"医药股强势走强 再鼎医药（09688）涨13.97%、药明生物（02269）涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657660793","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657660793?lang=zh_cn&edition=full","pubTime":"2026-08-07 10:06","pubTimestamp":1786068387,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股强势走强，再鼎医药 涨13.97%，药明生物涨5.41%，药明合联涨4.78%，药明康德涨4.73%，百济神州涨3.66%，荣昌生物涨2.33%，泰格医药涨2.07%。。国信证券表示，2026年版国家基本药物目录近期正式发布，这是目录时隔8年再次进行系统调整。新版目录结合疾病谱变化和临床用药需求，进一步补充慢性病、儿童、专科疾病及中医药优势病种用药，并对剂型、规格进行优化，提升药品在不同人群和医疗场景中的适用性。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987694","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422440.USD","LU0052750758.USD","LU0359202008.SGD","159938","LU0181495838.USD","BK4531","LU0588546209.SGD","02359","02268","LU0039217434.USD","LU2039709279.SGD","LU0856984785.SGD","LU1880383366.USD","LU1303224171.USD","BK4585","LU0140636845.USD","LU2328871848.SGD","LU2488822045.USD","06160","IE00B0JY6N72.USD","LU2242644610.SGD","LU0456846285.SGD","02269","LU1770034418.SGD","LU2045819591.USD","LU0348766576.USD","09995","BK1589","LU0348767384.USD","09939","LU0516422952.EUR","03347","BK1515","LU0043850808.USD","LU1794554557.SGD","BK1574","ZLAB","LU0051755006.USD","LU0516423174.USD","09688","LU0572944931.SGD","KURE","LU0823426308.USD","LU1720050803.USD","BK1583","SG9999002562.SGD","LU0348735423.USD","BK4526","LU0326950275.SGD","LU0327786744.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657530689","title":"荣昌生物：主动撤回伊立芙普α眼内注射液注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2657530689","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657530689?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:00","pubTimestamp":1786006840,"startTime":"0","endTime":"0","summary":"证券之星消息，荣昌生物(688331)08月06日在投资者关系平台上答复投资者关心的问题。投资者提问：7月28日药监局官网通知件信息显示，荣昌生物制药（烟台）股份有限公司的伊立芙普α眼内注射液在列，也就是本次上市申请未获批准。请问这是什么原因？荣昌生物回复：尊敬的投资者，您好！根据国家药监局最新审评建议，经审慎研究，公司决定主动撤回本次药品注册申请，并将根据国家药监局的有关安全性样本量的要求，进一步补充临床病例数研究后再次提交注册申请。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600027787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU2488822045.USD","09995","LU2148510915.USD","LU2328871848.SGD","688331","LU1064131003.USD","BK1583","BK1161","LU1064130708.USD","BK1574","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657508756","title":"港股开盘受压 恒指低开0.96% 友邦保险（01299）跌6.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657508756","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657508756?lang=zh_cn&edition=full","pubTime":"2026-08-06 09:30","pubTimestamp":1785979836,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股开盘受压，恒指低开0.96%，国企指数低开0.56%，恒生科技指数低开0.99%。友邦保险跌6.30%，创科实业跌4.94%，泡泡玛特跌3.35%，中芯国际跌2.72%，联想集团跌2.51%。友邦保险跌6.3%，据报中国税务机关已开始对境外保单收益征收个人所得税20%，堵住了长期存在的监管漏洞。内地股市昨日上升，上证指数低开后反复造好，收市上升1.5%，沪深两市成交额亦有所增加。投资者关注蓝筹股业绩表现，预期指数反复整固，继续于25,500至26,200点水平徘徊。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987596","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0261950470.USD","LU0456846285.SGD","LU0048575426.USD","LU0163747925.USD","03037","LU0235996351.USD","LU0588545730.USD","LU2153591404.USD","LU1048596156.SGD","LU0955669360.SGD","IE0008369823.USD","LU0784639295.USD","LU0149534421.HKD","LU2348774022.SGD","LU0823426480.USD","LU0873338254.USD","LU0096374516.USD","LU0359202008.SGD","LU1105468828.SGD","LU0210527791.USD","LU0264606111.USD","81299","LU1831875114.USD","LU2125910500.SGD","09995","LU0472753341.HKD","02800","LU0266013472.USD","LU0577902298.EUR","IE00B8L5B284.USD","LU0140636845.USD","LU0797268264.HKD","83115","HHImain","LU2177674079.SGD","SG9999000459.SGD","LU0192582467.USD","LU0823038988.USD","01299","LU0196878994.USD","IE00B3T34201.USD","IE00B031J352.USD","03115","LU1439102457.SGD","LU1328277881.USD","LU1568876251.USD","LU0762542818.HKD","LU0762540952.USD","LU0456842615.SGD","LU1152091754.HKD","LU0865486749.SGD","GB00BDT5M118.USD","LU2257852520.SGD","IE00B067MR52.USD","LU0117844026.USD","LU0289961442.SGD","LU1880383366.USD","LU1102505762.USD","IE00BZ08YT58.USD","LU0594300419.USD","LU0197773673.USD","IE00BKZH1Z71.USD","IE0004091025.USD","LU1629966141.USD","LU0540923850.HKD","LU0516423174.USD","LU1048588211.SGD","IE0032834883.USD","LU1119993845.HKD","LU0348814723.USD","SG9999002463.SGD","LU1807302812.USD","LU0197773160.USD","LU0878004406.USD","LU1981816686.USD","LU0327786744.USD","LU2271345857.HKD","IE00B031HY20.USD","LU1623119135.USD","LU0831093199.SGD","LU2153592121.USD","SG9999004303.SGD","BK1610","LU1712237335.SGD","LU0359201612.USD","LU0572939691.SGD","LU0261947096.USD","BBAX","LU0971096721.USD","LU0345776255.USD","LU0072913022.USD","LU0516422366.SGD","LU0049853897.USD","IE0004086264.USD","LU0043850808.USD","688331","LU1202635105.USD","LU0370786039.SGD","LU0821914370.USD","LU1400636491.USD","LU0823426308.USD","LU0918141705.HKD","LU0158827948.USD","LU0856984785.SGD","LU0228659784.USD","LU0164880469.USD","HK0000151867.HKD","LU0348816934.USD","LU1242518857.USD","LU0069063385.USD","LU1044874839.SGD","82800","LU1813983027.USD","LU2008162690.USD","LU2328871848.SGD","LU1008478684.HKD","IE0032431581.USD","IE0031814852.USD","BK1184","SG9999002562.SGD","LU1804176565.USD","LU1655091459.SGD","LU1642822792.SGD","LU0886674414.USD","LU1323998911.USD","IE0008368742.USD","IE00BFXG0V08.USD","LU0048580855.USD","LU0516423091.SGD","LU0672654166.SGD","LU1734074674.USD","AAGIY","LU0898667661.SGD","IE00B5TLWC47.USD","07300","513600","BK1583","LU2111349929.HKD","LU1670756490.USD","LU0541502299.USD","LU0878005551.USD","LU2028103732.USD","LU0572940350.SGD","LU0417516738.SGD","LU2023251221.USD","LU1130305938.SGD","LU0132412106.USD","LU1983260115.SGD","LU1880383440.USD","02833","LU0611395673.USD","LU0516422440.USD","IE0003851619.USD","IE00BZ08YR35.GBP","LU0738912210.USD","IE00BZ08YS42.EUR","BK1521","LU2449936058.SGD","LU0289739343.SGD","LU1400636657.SGD","LU2087589342.USD","LU0314109678.HKD","LU2226246903.HKD","LU0577902538.SGD","LU1196710864.SGD","LU2045819591.USD","LU1504937902.USD","LU0326948709.USD","SG9999001903.USD","LU0348735423.USD","BK1574","LU1481107354.HKD","LU2348773727.SGD","IE0003795394.USD","IE00BF5LJ272.USD","LU0251144936.SGD","07200","LU0880133367.SGD","LU1152091168.USD","LU0828237510.HKD","LU1023057109.AUD","LU0269904917.USD","SGXZ23171101.USD","LU0205439572.USD","SG9999000327.SGD","LU2089284900.SGD","07500","LU0149721374.USD","IE0009570106.USD","LU0985320562.USD","LU0054237671.USD","LU0188438112.USD","LU0543330483.HKD","LU1960683339.HKD","HK0000288743.USD","09115","LU0588545904.SGD","LU1046422090.SGD","SG9999014039.USD","SG9999004220.SGD","SG9999014005.SGD","LU0588545490.SGD","LU0823039010.USD","LU0828238088.HKD","LU1770036033.HKD","LU2152927971.USD","LU0541501648.USD","LU1044875133.USD","LU2265009873.SGD","HK0000288784.HKD","03419","LU0048597586.USD","LU0572944931.SGD","LU0345775950.USD","LU0511384066.AUD","LU0634319403.HKD","LU0918141887.USD","LU0315178854.USD","LU0441854154.USD","LU1048484197.HKD","LU0955648018.USD","LU0029875118.USD","LU3063872942.SGD","LU0607220059.USD","LU0106259558.USD","LU0594300179.USD","LU0396098781.USD","LU0823397103.USD","LU0819121731.USD","LU0979878070.USD","LU1044876610.USD","LU1328615791.USD","LU2039709279.SGD","LU0516422952.EUR","LU0228367735.SGD","LU1400636574.HKD","LU0605514214.HKD","EPP","LU0165289439.USD","LU1956131251.USD","LU2089283258.USD","LU0557290698.USD","LU0882747503.HKD","LU0320764755.SGD","LU0762541174.USD","LU1688375341.USD","LU0509642566.USD","HSI","HSTECH","LU0414403682.SGD","LU0823397285.USD","LU0819123356.HKD","LU0630378692.HKD","IE0008368411.USD","LU0067412154.USD","LU0630378429.USD","LU0577902611.USD","MCHmain","LU0158827781.USD","LU0128522157.USD","LU0181495838.USD","IE00B8HQ1Z84.USD","LU1242518931.SGD","LU0057025933.USD","BK1589","LU0348788117.USD","LU0011963245.USD","BK1161","SG9999014021.USD","IE00B0169L03.USD","LU0048388663.USD","LU0251143458.SGD","LU0577902454.USD","LU0084288322.USD","LU1363072403.SGD","LU0072462343.USD","LU1282648689.USD","LU1645745479.HKD","LU0831103253.SGD","LU1969619763.USD","LU0211977185.USD","LU0501845795.SGD","LU1993786604.SGD","LU0650527681.SGD","IE00B97KM107.HKD","LU0106252389.USD","SG9999001689.USD","LU1439103000.SGD","LU0261950983.USD","LU0061477393.USD","LU0877626530.USD","LU0955623706.USD","SG9999014013.SGD","LU0169518387.USD","LU0577902371.SGD","LU0675040207.SGD","IE00B031HW06.USD","LU1102505929.USD","LU1481012133.USD","SG9999001846.SGD","LU1568876335.HKD","IE00BYQQ9H92.USD","LU0828237940.HKD","LU1821325948.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657508960","title":"港股异动 | 荣昌生物(09995)高开近4% 预计上半年归母净利润约为47亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657508960","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657508960?lang=zh_cn&edition=full","pubTime":"2026-08-06 09:24","pubTimestamp":1785979466,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荣昌生物(09995)高开近4%，截至发稿，涨3.94%，报85.8港元，成交额1364.22万港元。消息面上，荣昌生物发布业绩，预计上半年实现营业收入约58.5亿元，同比增加约433%；预计实现归母净利润约为47亿元，与上年同期相比，实现扭亏为盈；预计归属于母公司所有者扣除非经常性损益后的净利润约43亿元。公告显示，业绩增长主要由于公司核心产品泰它西普、维迪西妥单抗国内销售收入持续增长；公司与艾伯维就RC148签署独家授权许可协议，艾伯维将获得RC148 在大中华区以外地区的开发、生产和商业化的独家权利，公司技术授权收入大幅增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1476595.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688331","KCAI","09995","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657726255","title":"礼来上半年替尔泊肽大卖277亿美元；石药集团与阿斯利康成立合资公司丨医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2657726255","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657726255?lang=zh_cn&edition=full","pubTime":"2026-08-06 07:00","pubTimestamp":1785970805,"startTime":"0","endTime":"0","summary":"丨2026年8月6日星期四丨NO.1礼来：上半年替尔泊肽大卖277亿美元，中国区收入增长73%8月5日，礼来披露半年度业绩，公司上半年实现总营收427.73亿美元，同比增长49%。从地区分布来看，上半年美国市场收入265.32亿美元，同比增长37%，中国市场收入16.35亿美元，同比增长73%。上半年，礼来8款核心产品合计收入290.77亿美元，占总营收68%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608063832986566.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608063832986566.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["KURE","LU2462157665.USD","LU0820561909.HKD","BK4585","IE00B031HY20.USD","LU2264538146.SGD","IE00B4JS1V06.HKD","IE00B5MMRT66.SGD","688331","LU1829250122.USD","IE0002141913.USD","LU1868836914.USD","LU1983299246.USD","SGXZ99366536.SGD","LU0315179316.USD","IHE","BK1500","LU0238689110.USD","GB00BDT5M118.USD","LU1328277881.USD","LU1093756168.USD","SG9999001176.USD","IE0005OL40V9.USD","BK4599","CANC","SG9999015952.SGD","LU0323591593.USD","LU2087625088.SGD","IE00BZ08YT58.USD","WDNA","JDOC","IE00B1BXHZ80.USD","LU0471298694.HKD","LU2357305700.SGD","LU0225283273.USD","BK1191","LU1960683339.HKD","LU2750360997.AUD","SG9999018857.SGD","IE00BKDWB100.SGD","LU0823416689.USD","ONC","BK4588","LU1770034418.SGD","LU0385154629.USD","LU2328871848.SGD","LU1061106388.HKD","LU2168564149.EUR","IE00BJLML261.HKD","HK0000165453.HKD","IE00BWXC8680.SGD","LU0501845795.SGD","LU0122379950.USD","LU2491050071.SGD","LU0588546209.SGD","SG9999013999.USD","LU0256863902.USD","LU1951186391.HKD","LU1145028129.USD","IE00B775H168.HKD","IE0004445015.USD","LU0820562030.AUD","LU0234572021.USD","LU2168564222.USD","BK1583","IE0008368742.USD","SG9999001176.SGD","LLYZ","LU2237443622.USD","LU2028103732.USD","LU2756315664.SGD","THNR","IE00B2B36J28.USD","LU2361044865.SGD","LU0006306889.USD","LU1303224171.USD","LU1226287529.USD","BK1521","AZN","LU2552382215.SGD","LU0432979614.USD","RXL","LU0097036916.USD","LU2023250330.USD","TRUH","LU1988902786.USD","IE00BN29S564.USD","LU1069344957.HKD","LU0058720904.USD","OZEM","LU1804176565.USD","SG9999004220.SGD","CURE","LU0140636845.USD","LU2746668461.USD","LU1551013342.USD","LU1993786604.SGD","LU0820561818.USD","XLV","LU0210536198.USD","LU2023250504.SGD","BK4568","LU0310800379.SGD","IE0001KFT4U8.USD","LU1251922891.USD","LU0256863811.USD","BK1161","AGNG","01093","LU2461242641.AUD","LU2213496289.HKD","SGXZ31699556.SGD","LU1868837136.USD","LU2108987350.USD","LLY","LU2168563687.JPY","LU0353189680.USD","LU0079474960.USD","LU0417517546.SGD","LU2456880835.USD","SGXZ57979304.SGD","LU1232071149.USD","SG9999015978.USD","ELIL","IE00BZ08YR35.GBP","LU1712237335.SGD","IE00BK4W5L77.USD","LU1152091168.USD","LU0094547139.USD","SG9999017495.SGD","LU2039709279.SGD","AZNH","LU2552382132.HKD","LU0106261372.USD","IE00BJJMRZ35.SGD","LU1989771016.USD","MEDX","LU2417539215.USD","LU2471134952.CNY","LU1813983027.USD","LU0326950275.SGD","LU0823434740.USD","IE00B4R5TH58.HKD","LU1057294990.SGD","LU1969619763.USD","IE00BJJMRX11.SGD","LU0320765992.SGD","SG9999014880.SGD","LU0266013472.USD","LU1008478684.HKD","LU1023059063.AUD","LU2471134523.USD","IE00BJJMRY28.SGD","LU1974910355.USD","BK1515","LU0061475181.USD","LU1267930573.SGD","LU2112291526.USD","LU1623119135.USD","LU2168564065.EUR","LU0943347566.SGD","LU2089984988.USD","LU1807302812.USD","LU0823434583.USD","LU0203202063.USD","LU2168564495.EUR","IE00B7KXQ091.USD","LU2023251221.USD","LU0683600562.USD","LU1064131342.USD","LU0787776722.HKD","LU2361044949.HKD","LU0174119429.USD","LU0345770308.USD","LU2746668974.SGD","LU1720051017.SGD","IE00BKPKM429.USD","LU2237443465.HKD","SG9999014898.SGD","ILDR","LU0133085943.USD","LU2756315318.SGD","LU1226288253.USD","LU2271345857.HKD","LU2237443549.SGD","LU2237438978.USD","LU2211815571.USD","IE0009355771.USD","BK4007","LU0466842654.USD","LU0456855351.SGD","LU0353189763.USD","BK4533","LU2111349929.HKD","MHIP","LU2063271972.USD","IXJ","IE00B543WZ88.USD","688235","LU1917777945.USD","LU0109394709.USD","LU0354030511.USD","LU0198837287.USD","LU0109391861.USD","MEDI","HRTS","IE00BFSS8Q28.SGD","IE00BZ08YS42.EUR","LU2236285917.USD","LU1280957306.USD","LU0880133367.SGD","LU2089283258.USD","BK4581","LU2361045086.USD","IE0008369823.USD","LU0114720955.EUR","FTXH","LU1868836591.USD","LU1629891620.HKD","LU1868837300.USD","LU2324357040.USD","LU1291159041.SGD","LU2265009873.SGD","LU0345770993.USD","IE00B3T34201.USD","LU2750360641.GBP","LU0882574139.USD","LU0289739699.SGD","LU1814569148.SGD","LU2360106947.USD","LU2468319806.SGD","LU1551013425.SGD","ELIS","LU0029864427.USD","LU2471134879.HKD","LU0882574055.USD","LU2491050154.USD","IE00B1XK9C88.USD","LU0786609619.USD","LU1720051108.HKD","SGXZ51526630.SGD","LU2471134796.USD","LU2491049909.HKD","LU1719994722.HKD","IE00BFSS7M15.SGD","LU2237443895.HKD","LU0314109678.HKD","LU2106854487.HKD","IYH","LLII","LU0354030438.USD","LU2237443382.USD","LU1127390331.HKD","LU2462591350.SGD","LU0689472784.USD","LU1548497426.USD","SG9999015986.USD","LU1226287792.SGD","LU1267930730.SGD","LU1979441026.SGD","LU0158827948.USD","LU0203201768.USD","LU2896262040.SGD","VHT","LU1035775433.USD","BK1574","SG9999014914.USD","LU1226288170.HKD","LU0640476718.USD","LU0096364046.USD","IE00BJT1NW94.SGD","IE00BK4W5M84.HKD","LU0672654240.SGD","LU2602419157.SGD","LLYX","LU0307460666.USD","BK1588","LU0708994859.HKD","LU2552382058.USD","SG9999015945.SGD","BK4534","LU0889565916.HKD","LU0128525929.USD","LU0072913022.USD","LU1093756325.SGD","LU2237443978.SGD","LU0158827781.USD","FHLC","SG9999014906.USD","LU1152091754.HKD","IE0004445239.USD","SGXZ81514606.USD","LU0320765059.SGD","PJP","LU0471298777.SGD","09995","LU1226287875.USD","LU0708995401.HKD","LU0316494557.USD","IE00BFTCPJ56.SGD","LU1366192091.USD","SG9999018865.SGD","LU1868836757.USD","LU2089284900.SGD","LU0067412154.USD","LU1323610961.USD","06160","GDOC","LU0964807845.USD","TMED","PPH","BK4516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657454923","title":"荣昌生物(09995.HK)预计2026年中期归母净利润约47亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657454923","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657454923?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:32","pubTimestamp":1785929525,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2328871848.SGD","09995","BK1161","BK1583","BK1574","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134277843","title":"荣昌生物(09995)发布2026年中期业绩预告：营收约58.5亿元，同比增433%","url":"https://stock-news.laohu8.com/highlight/detail?id=1134277843","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134277843?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:31","pubTimestamp":1785929488,"startTime":"0","endTime":"0","summary":"2026年8月5日，荣昌生物披露2026年中期业绩预告。公司预计截至2026年6月30日止六个月内：。公司与艾伯维签署RC148独家授权许可协议，确认的技术授权收入显著提升。公司提示，以上数据为初步测算结果，最终财务数据以2026年中期报告为准。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657488735","title":"荣昌生物：预计2026年1-6月营业收入58.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657488735","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657488735?lang=zh_cn&edition=full","pubTime":"2026-08-05 18:00","pubTimestamp":1785924040,"startTime":"0","endTime":"0","summary":"证券之星消息，荣昌生物发布业绩预告，预计2026年1-6月营业收入58.5亿元。荣昌生物制药（烟台）股份有限公司董事会2026 年 8 月 6 日荣昌生物2026年一季报显示，一季度公司主营收入6.56亿元，同比上升24.76%；归母净利润3.28亿元，同比上升229.06%；扣非净利润-3499.1万元，同比上升86.12%；负债率46.66%，投资收益-37.26万元，财务费用921.32万元，毛利率82.18%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500033400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688331","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154379028","title":"荣昌生物：预计2026年上半年净利润约47亿元，实现扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1154379028","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154379028?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:13","pubTimestamp":1785921235,"startTime":"0","endTime":"0","summary":"8月5日，$荣昌生物(09995)$公告，预计2026年半年度营业收入约58.5亿元，同比增加约433%；归属于母公司所有者的净利润约47亿元，上年同期净亏损4.5亿元，实现扭亏为盈；扣非净利润约43亿元，亦实现扭亏为盈。业绩增长主要因核心产品泰它西普、维迪西妥单抗国内销售收入持续增长，以及与艾伯维就RC148签署独家授权许可协议带来的技术授权收入大幅增加。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","LU1064130708.USD","LU1969619763.USD","BK1574","LU2148510915.USD","LU1064131003.USD","LU2488822045.USD","BK0239","09995","688331","LU2328871848.SGD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657051498","title":"8月5日荣昌生物涨5.79%，万家行业优选LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657051498","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657051498?lang=zh_cn&edition=full","pubTime":"2026-08-05 16:40","pubTimestamp":1785919234,"startTime":"0","endTime":"0","summary":"证券之星消息，8月5日荣昌生物涨5.79%，收盘报117.8元，换手率1.83%，成交量6.5万手，成交额7.56亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共121家，其中持有数量最多的公募基金为万家基金的万家行业优选LOF。万家行业优选LOF的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500030197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","LU1969619763.USD","09995","LU2148510915.USD","LU2328871848.SGD","160916","LU1064131003.USD","BK1583","LU2488822045.USD","BK1574","BK1161","688331","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657563523","title":"股市必读：荣昌生物新发布《荣昌生物关于2026年第一次以集中竞价交易方式回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657563523","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657563523?lang=zh_cn&edition=full","pubTime":"2026-08-05 01:44","pubTimestamp":1785865454,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，荣昌生物报收于111.35元，上涨3.52%，换手率1.61%，成交量5.73万手，成交额6.37亿元。公司公告汇总荣昌生物关于2026年第一次以集中竞价交易方式回购公司股份的进展公告荣昌生物制药（烟台）股份有限公司于2026年7月19日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案，回购期限为2026年7月19日至2027年7月18日，拟回购金额为2,500万元至5,000万元，回购价格不超过149元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500001776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2148510915.USD","BK1161","LU1064130708.USD","LU2488822045.USD","688331","BK0239","BK1574","LU1064131003.USD","LU1969619763.USD","BK1583","LU2328871848.SGD","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192699378","title":"荣昌生物更新7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1192699378","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192699378?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:57","pubTimestamp":1785833851,"startTime":"0","endTime":"0","summary":"荣昌生物制药（烟台）股份有限公司于2026年8月4日披露了截至2026年7月31日的证券变动月报表。报告显示，公司本月无新增发行和注销股份，整体股本结构保持稳定。公告同步披露，公司7月期间未发生由股票期权或股权激励计划导致的新股发行或库藏股转让。据悉，本次公告由公司董事王威东签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0377},{"period":"1month","weight":0},{"period":"3month","weight":-0.0767},{"period":"6month","weight":0.0274},{"period":"1year","weight":0.2106},{"period":"ytd","weight":0.1458}],"compareEarnings":[{"period":"1week","weight":-0.0052},{"period":"1month","weight":0.0434},{"period":"3month","weight":-0.0218},{"period":"6month","weight":-0.0441},{"period":"1year","weight":-0.0085},{"period":"ytd","weight":-0.0091}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"荣昌生物制药（烟台）股份有限公司是一家主要从事生物医药研究、生物医药服务及生物医药生产和销售的中国公司。该公司专注于抗体药物偶联物（ADC）、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域。该公司的主要产品包括泰它西普、维迪西妥单抗、RC28-E等。该公司的产品主要应用于自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.110172},{"month":2,"riseRate":0.666667,"avgChangeRate":0.167223},{"month":3,"riseRate":0.5,"avgChangeRate":0.012545},{"month":4,"riseRate":0.833333,"avgChangeRate":0.095268},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.049233},{"month":6,"riseRate":0.666667,"avgChangeRate":0.089626},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.010221},{"month":8,"riseRate":0.5,"avgChangeRate":0.058705},{"month":9,"riseRate":0.6,"avgChangeRate":0.099222},{"month":10,"riseRate":0.4,"avgChangeRate":0.027845},{"month":11,"riseRate":1,"avgChangeRate":0.038747},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.053467}],"exchange":"SEHK","name":"荣昌生物","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荣昌生物,09995,荣昌生物股票,荣昌生物股票老虎,荣昌生物股票老虎国际,荣昌生物行情,荣昌生物股票行情,荣昌生物股价,荣昌生物股市,荣昌生物股票价格,荣昌生物股票交易,荣昌生物股票购买,荣昌生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}